Feb. 3, 2012 (GLOBE NEWSWIRE) -- Caris Diagnostics, specializing in academic-caliber anatomic pathology services( SAYS WHO---CARIS)
, today announced a company name change to Miraca Life Sciences following its November 2011 acquisition by Tokyo-based Miraca Holdings Inc., Japan's largest clinical diagnostics and laboratory testing service provider. The name change, which is effective February 20, 2012, follows a (UN)successful integration process and will be reflected in all marketing and communications.
"The new name is a logical step as we complete the successful ownership transition of this world-class diagnostics organization (Who sells Tests that are unproven and made to rip off the insurance industry and medicare),"
said Takeo Hayashi, Chairman and CEO of the newly-named Miraca Life Sciences. "While the name has changed, the fundamental value proposition has not: a unique, high quality pathology practice with an abiding commitment to diagnostic excellence and improved patient care." HAHAHAHAAHAH AYH SOOO
Since 2005, Caris Diagnostics has established an unprecedented reputation among clinicians ( and hated by Pathologists and Academics) by creating an innovative, best-in-class practice that results in improved patient care. The word "Miraca" is a combination of the Japanese words 'future' and 'science', so the new corporate name is a natural fit for the company's mission and Miraca's global network of employees, clinicians and patients.